Alyeska Investment Group
BCRX icon

Alyeska Investment Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Alyeska Investment Group’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-450,000
Closed -$2.21M – 411
2017
Q4 		$2.21M Hold
450,000
– – 0.02% 303
2017
Q3 		$2.36M Buy
+450,000
New +$2.36M 0.02% 325